Search Orphan Drug Designations and Approvals
-
Generic Name: | Alitretinoin |
---|---|
Date Designated: | 04/10/1992 |
Orphan Designation: | Treatment of acute promyelocytic leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Ligand Pharmaceuticals, Inc. 10275 Science Center Dr. San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-